TREVI THERAPEUTICS INC (TRVI:NASDAQ)
$15.9 -0.01 (-0.0629%)
Analysed TREVI THERAPEUTICS INC (TRVI:NASDAQ) News Sources
Trevi Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 5, 2026
28-04-2026
yahoo.com
Trevi Therapeutics Announces Oral Presentation and Multiple Posters Accepted at the American Thoracic Society (ATS) 2026 International Conference
30-04-2026
yahoo.com
Trevi Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates
05-05-2026
yahoo.com
Trevi Therapeutics Q1 Earnings Call Highlights
06-05-2026
marketbeat.com
Trevi Therapeutics Maps Haduvio Chronic Cough Push, Sees Cash Runway Into 2030
09-05-2026
marketbeat.com
Trevi Therapeutics Is Up 100%, Pivotal bioVenture Adds Anyway. Here's Why That Matters.
03-06-2026
fool.com
Trevi Therapeutics Announces Upcoming June and July Event Schedule
17-06-2026
yahoo.com
Trevi Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026
30-07-2026
yahoo.com
Trevi Therapeutics to Participate in Upcoming September Conferences
03-09-2026
yahoo.com
Trevi Therapeutics (TRVI) Stock Trades At A Premium To Fair Value
05-09-2026
yahoo.com
What is the current price of TREVI THERAPEUTICS INC (TRVI:NASDAQ)?
The current price of TREVI THERAPEUTICS INC (TRVI:NASDAQ) is $15.9.
TREVI THERAPEUTICS INC (TRVI:NASDAQ) absolute price change since previous trading day?
The absolute price change of TREVI THERAPEUTICS INC (TRVI:NASDAQ) since the previous trading day is $-0.01.
TREVI THERAPEUTICS INC (TRVI:NASDAQ) percentage price change since previous trading day?
The percentage price change of TREVI THERAPEUTICS INC (TRVI:NASDAQ) since the previous trading day is -0.0629%.
What is the most recent average sentiment score for TREVI THERAPEUTICS INC (TRVI:NASDAQ)?
The most recent average sentiment score for TREVI THERAPEUTICS INC (TRVI:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for TREVI THERAPEUTICS INC (TRVI:NASDAQ)?
The most recent sentiment for TREVI THERAPEUTICS INC (TRVI:NASDAQ) is .
SEC-8K** Filing Available For TREVI THERAPEUTICS INC (TRVI:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.